Agilent has announced the creation of a center for neurometabolomics research and training in the city of Daegu, South Korea.
The center will serve as the base for the company’s collaboration with the department of brain science at the Daegu Gyeongbuk Institute of Science and Technology (DGIST) and the city.
This is Agilent’s first collaboration in Asia for metabolomics research in brain science.
Metabolomics is the study of the small molecules produced during metabolism. Through metabolomics, scientists and researchers are able to discover biomarkers for neurological diseases.
“The department of brain science at DGIST aims to facilitate neuroscience discovery and education, and apply our knowledge to improve brain health,” said professor Gabriele Ronnett, head of the neuroscience department at DGIST.”
“The goal of this center is not only to lead global collaborations in neurometabolomics but to foster and train researchers who will work in this area,” said professor Eun-Kyoung Kim of the department of brain science at DGIST, soon to be appointed head of the Neurometabolomics Research and Training Center.
Under a memorandum of understanding, Agilent will provide DGIST with early access to novel technology and software development.
The center will also be a reference site for Agilent customers in Asia who are interested in metabolomics and brain science.
“Metabolomics is a powerful, emerging discipline with a broad range of applications, and for many years Agilent has been collaborating with leading universities on clinical research, drug development, environmental toxicology, crop optimization and food science,” said Rod Minett, general manager of Agilent’s life sciences business in South Korea and the South Asia Pacific region.
“Today, we have the chance to be involved in metabolomics research for neuroscience as our instruments can help scientists obtain and analyse data quickly and reliably. Importantly, we work with them to investigate questions they couldn’t answer before.”
